Figure 5 shows that diabetes increased HMGB1 (A), TNFα (B), and IL1β (C) levels in the diabetic retina at both two (top) and six months (bottom), which were significantly reduced by systemic treatment with glycyrrhizin (p < 0.05, one-way ANOVA analyses). The gene discussed is TNF; the disease is diabetes mellitus.